Cochlear (Germany) Performance
| OC5 Stock | EUR 120.00 4.00 3.23% |
The firm shows a Beta (market volatility) of 0.2, which signifies not very significant fluctuations relative to the market. As returns on the market increase, Cochlear's returns are expected to increase less than the market. However, during the bear market, the loss of holding Cochlear is expected to be smaller as well. At this point, Cochlear Limited has a negative expected return of -0.36%. Please make sure to confirm Cochlear's coefficient of variation, variance, jensen alpha, as well as the relationship between the standard deviation and information ratio , to decide if Cochlear Limited performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Cochlear Limited has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in March 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Forward Dividend Yield 0.0208 | Payout Ratio 0.8151 | Forward Dividend Rate 2.58 | Ex Dividend Date 2026-03-19 |
1 | Envoy Medical plans Dec. 11 chat with first Acclaim implant patient - Stock Titan | 12/04/2025 |
2 | Cochlear is still a long term growth story you should listen to - Stocks Down Under | 01/08/2026 |
Cochlear |
Cochlear Relative Risk vs. Return Landscape
If you would invest 15,098 in Cochlear Limited on November 19, 2025 and sell it today you would lose (3,098) from holding Cochlear Limited or give up 20.52% of portfolio value over 90 days. Cochlear Limited is currently producing negative expected returns and takes up 2.4423% volatility of returns over 90 trading days. Put another way, 21% of traded stocks are less volatile than Cochlear, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Cochlear Target Price Odds to finish over Current Price
The tendency of Cochlear Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 120.00 | 90 days | 120.00 | close to 99 |
Based on a normal probability distribution, the odds of Cochlear to move above the current price in 90 days from now is close to 99 (This Cochlear Limited probability density function shows the probability of Cochlear Stock to fall within a particular range of prices over 90 days) .
Cochlear Price Density |
| Price |
Predictive Modules for Cochlear
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Cochlear Limited. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Cochlear Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Cochlear is not an exception. The market had few large corrections towards the Cochlear's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Cochlear Limited, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Cochlear within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.36 | |
β | Beta against Dow Jones | 0.20 | |
σ | Overall volatility | 5.46 | |
Ir | Information ratio | -0.18 |
Cochlear Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Cochlear for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Cochlear Limited can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Cochlear Limited generated a negative expected return over the last 90 days | |
| About 56.0% of the company shares are owned by institutional investors |
Cochlear Fundamentals Growth
Cochlear Stock prices reflect investors' perceptions of the future prospects and financial health of Cochlear, and Cochlear fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Cochlear Stock performance.
| Return On Equity | 0.18 | ||||
| Return On Asset | 0.11 | ||||
| Profit Margin | 0.15 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 7.81 B | ||||
| Shares Outstanding | 65.4 M | ||||
| Price To Earning | 43.54 X | ||||
| Price To Book | 7.01 X | ||||
| Price To Sales | 3.38 X | ||||
| Revenue | 2.34 B | ||||
| Gross Profit | 1.7 B | ||||
| EBITDA | 562 M | ||||
| Net Income | 388.9 M | ||||
| Cash And Equivalents | 79.01 M | ||||
| Cash Per Share | 1.37 X | ||||
| Total Debt | 874.7 M | ||||
| Debt To Equity | 25.20 % | ||||
| Book Value Per Share | 17.65 X | ||||
| Cash Flow From Operations | 376.5 M | ||||
| Earnings Per Share | 3.15 X | ||||
| Total Asset | 2.83 B | ||||
| Retained Earnings | 777.3 M | ||||
About Cochlear Performance
By analyzing Cochlear's fundamental ratios, stakeholders can gain valuable insights into Cochlear's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Cochlear has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Cochlear has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Cochlear Limited provides implantable hearing solutions in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cochlear Limited was incorporated in 1983 and is headquartered in Sydney, Australia. COCHLEAR LTD operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 3500 people.Things to note about Cochlear Limited performance evaluation
Checking the ongoing alerts about Cochlear for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Cochlear Limited help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Cochlear Limited generated a negative expected return over the last 90 days | |
| About 56.0% of the company shares are owned by institutional investors |
- Analyzing Cochlear's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Cochlear's stock is overvalued or undervalued compared to its peers.
- Examining Cochlear's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Cochlear's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Cochlear's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Cochlear's stock. These opinions can provide insight into Cochlear's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Cochlear Stock analysis
When running Cochlear's price analysis, check to measure Cochlear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cochlear is operating at the current time. Most of Cochlear's value examination focuses on studying past and present price action to predict the probability of Cochlear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cochlear's price. Additionally, you may evaluate how the addition of Cochlear to your portfolios can decrease your overall portfolio volatility.
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |